The global Antibody Drug Conjugate (ADC) market is poised for significant growth, projected to expand from ADCs represent a breakthrough in targeted cancer therapy, combining the precision of monoclonal antibodies with the potency of cytotoxic drugs to selectively destroy cancer cells while minimizing harm to healthy tissues. This growth is fueled by rising cancer incidence worldwide,...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek